Kinome Activity Profiling For Drug Repurposing
Understand the MOA of failed or on-the-shelve drugs to breathe new music into them.
Repurposing abandoned PKI candidates
Repurposing offers lucrative opportunities for pharmaceutical companies, since further development of approved PKIs or abandoned candidates for new indications involves a less risky process, is more cost-effective, and less-time consuming than developing a completely novel PKI candidate.
The role of Kinome Activity Profiling in drug repurposing is becoming increasingly important as the pharmaceutical industry looks for new ways to develop drugs. By understanding the role of specific kinases in disease, researchers can identify potential targets for new drugs. Additionally, we can use Kinome Activity Profiling to identify existing drugs that may be effective against a particular disease. Kinome Activity Profiling is a powerful tool to help researchers identify new therapeutic targets and repurpose existing drugs. As the pharmaceutical industry continues to face challenges in drug development, Kinome Activity Profiling will play an increasingly important role in finding new treatments for patients.
Our advantages
Pepscopes’ quantitative, targeted mass spectrometry technology for biomarker and MOA analyses in a range of human cell samples. A solution to help you compose a melody that starts with the end in mind and provides integrated feedback.
High sensitivity to quantify low abundant alternative targets
Multiplexity to identify unknown alternative targets
Endogenous activity mechanistic assessment of specific biological pathways
Pepscope’s proprietary platform can be used in a broad spectrum of therapeutic areas. Contact us to learn more about how our technology can make an impact across various indications.
Start a conversation and start hitting the right notes.
